2028년까지 북미 의료용 마리화나 시장 예측 - 코로나19 영향 및 지역 분석 - 제품 유형별(건조 형태 및 추출물 형태), 용도별(통증 관리, 뚜렛병, 알츠하이머병, 편두통, 우울증 및 불안, 다발성경화증, 암 등) 및 유통채널(소매약국, 전자상거래 등)

북미 의료용 마리화나 시장은 2022년 71억 7017만 달러에서 2028년 207억 6041만 달러로 성장할 것으로 예상됩니다. 2022년부터 2028년까지 연평균 성장률(CAGR) 19.4%를 기록할 것으로 추정됩니다. ;

의료용 마리화나 제품 승인 증가로 북미 의료용 마리화나 시장 성장 가속화

< p>마리화나의 의학적 잠재력으로 인해 다양한 연구자들과 회사들이 마리화나를 의료 용도로 사용하게 되었습니다. 예를 들어, 테트라히드로칸나비놀(THC)은 주로 의약품 생산에 사용됩니다. 미국 식품의약국(FDA)은 나볼린을 유효성분으로 함유한 세사메트(Cesamet)와 같은 THC 기반 의약품을 THC와 같은 구조를 갖는 합성 유래 제품으로 승인했습니다. Cesamet은 화학요법을 받는 환자의 메스꺼움 치료를 위해 처방됩니다. Cesamet은 일반적으로 다른 약물이 메스꺼움과 구토를 조절할 수 없을 때 처방됩니다. FDA는 또한 미국에서 마리놀(Marinol)과 신드로스(Syndros)를 치료 용도로 승인했습니다. 마리놀과 신드로스는 대마초의 향정신성 성분으로 간주되는 합성 9-THC인 활성 성분인 드로나비놀을 함유하고 있습니다. 마리놀과 신드로스 약물은 AIDS의 적응증 중 하나로 개발된 소모성 증후군 환자의 식욕을 자극하기 위해 처방됩니다. 마찬가지로, 다양한 마리화나 기반 제품이 승인되었거나 임상 시험 중입니다. 예를 들어, nabiximols(Sativex)는 캐나다에서 상용화되는 승인된 약물입니다. Nabiximols는 다발성 경화증과 관련된 경직 및 신경병성 통증을 치료하는 데 사용되는 대마초 추출물입니다. THC와 기타 칸나비디올(CBD)을 혼합하여 제조되었습니다. 2020년 2월, 캐나다 회사인 CanaQuest Medical Corp는 캐나다 보건부에 멘타비놀의 생산 및 상업화 승인을 신청했습니다. Mentabinol은 THC 기반 제품이며 대마초법에 따라 승인 신청이 제출되었습니다. 위에서 언급한 마리화나 기반 제품에 대한 FDA의 승인 증가가 의료용 마리화나 시장을 주도하고 있습니다.

북미 의료용 마리화나 시장 개요

북미 의료용 마리화나 시장은 미국, 캐나다, 멕시코로 구분됩니다. 의료용 마리화나 시장은 미국에서 가장 큰 점유율을 차지하는 것으로 추정됩니다. 의료용 마리화나 시장의 성장은 혁신적인 치료 응용을 탐구하기 위한 연구 및 협력 증가, 의료용 마리화나에 대한 인식 제고, 지역 내 핵심 기업의 존재에 기인할 수 있습니다. 또한, 지역 전반에 걸쳐 인구 노령화 증가로 인해 시장 성장도 촉진될 것입니다.

2028년까지 북미 의료용 마리화나 시장 수익 및 예측(미국) 백만 달러)

북미 의료용 마리화나 시장 세분화

북미 의료용 마리화나 시장은 제품 유형, 적용 분야, 유통 채널 및 국가로 분류됩니다.

북미 의료용 마리화나 시장은 제품 유형에 따라 건조 형태와 추출물 형태로 분류됩니다. 추출물 형태 부문은 2022년 북미 의료용 마리화나 시장에서 더 큰 점유율을 차지했습니다.

응용 프로그램을 기준으로 북미 의료용 마리화나 시장은 통증 관리, 투렛병, 알츠하이머병, 편두통, 우울증 및 불안, 다발성 경화증, 암 등. 통증 관리 부문은 2022년 북미 의료용 마리화나 시장에서 가장 큰 점유율을 차지했습니다.

유통 채널을 기준으로 북미 의료용 마리화나 시장은 소매 약국, - 상업 및 기타. 소매 약국 부문은 2022년 북미 의료용 마리화나 시장에서 가장 큰 점유율을 차지했습니다.

국가별로 북미 의료용 마리화나 시장은 미국, 캐나다, 그리고 멕시코. 미국은 2022년 북미 의료용 마리화나 시장을 장악했습니다.

Aphria, Inc.; 카나퀘스트 메디컬 코퍼레이션(CanaQuest Medical Corporation); 캐노피 성장 공사; 에메랄드 헬스 테라퓨틱스 인코포레이티드(Emerald Health Therapeutics Inc.); GW 제약; 마리칸 주식회사; Organigram Holdings Inc.; Panaxia Pharmaceutical Industries Ltd.; 포에나 홀딩스 주식회사; VIVO Cannabis Inc는 북미 의료용 마리화나 시장에서 활동하는 선두 기업입니다.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Medical Marijuana Market – by Product

1.3.2 North America Medical Marijuana Market – by Application

1.3.3 North America Medical Marijuana Market – by Distribution Channel

1.3.4 North America Medical Marijuana Market – by Country

2. North America Medical Marijuana Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Medical Marijuana Market – Market Landscape

4.1 Overview

4.2 North America – PEST Analysis

4.3 Expert Opinion

5. North America Medical Marijuana Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Approvals of Medical Marijuana Products

5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America

5.2 Market Restraints

5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana

5.3 Market Opportunities

5.3.1 Increase in Job Opportunities in Marijuana Industry

5.4 Future Trends

5.4.1 Widespread Distribution of Medical Marijuana

5.5 Impact Analysis

6. Medical Marijuana Market – North America Analysis

6.1 North America Medical Marijuana Market Revenue Forecast and Analysis

7. North America Medical Marijuana Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

7.3 Dried Form

7.3.1 Overview

7.3.2 Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Extract Form

7.4.1 Overview

7.4.2 Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8. North America Medical Marijuana Market Analysis – by Application

8.1 Overview

8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

8.3 Pain Management

8.3.1 Overview

8.3.2 Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Tourette’s

8.4.1 Overview

8.4.2 Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Alzheimer’s Disease

8.5.1 Overview

8.5.2 Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Migraines

8.6.1 Overview

8.6.2 Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Depression and Anxiety

8.7.1 Overview

8.7.2 Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Multiple Sclerosis

8.8.1 Overview

8.8.2 Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Cancer

8.9.1 Overview

8.9.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Medical Marijuana Market – by Distribution Channel

9.1 Overview

9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

9.3 Retail Pharmacy

9.3.1 Overview

9.3.2 Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.4 E-Commerce

9.4.1 Overview

9.4.2 E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Medical Marijuana Market Revenue and Forecast to 2028 – Country Analysis

10.1 Overview

10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

10.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.2 US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 US: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.2 Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Canada: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.2 Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 Mexico: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

11. North America Medical Marijuana Market – Industry Landscape

11.1 Overview

11.2 Growth Strategies in the North America Medical Marijuana Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 VIVO Cannabis Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Panaxia Pharmaceutical Industries Ltd.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Phoena Holdings Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Emerald Health Therapeutics Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 MARICANN INC.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Aphria, Inc.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Canopy Growth Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 CanaQuest Medical Corporation

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 GW Pharmaceuticals

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Organigram Holdings Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms for North America Medical Marijuana Market

LIST OF TABLES

Table 1. US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. US: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 3. US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4. Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5. Canada: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 6. Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7. Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. Mexico: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 9. Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10. Organic Developments in the Medical Marijuana Market

Table 11. Inorganic Developments in the Medical Marijuana Market

Table 12. Glossary of Terms for North America Medical Marijuana Market

LIST OF FIGURES

Figure 1. North America Medical Marijuana Market Segmentation

Figure 2. North America Medical Marijuana Market, By Country

Figure 3. North America Medical Marijuana Market Overview

Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market

Figure 5. US to Show Remarkable Growth During Forecast Period

Figure 6. North America PEST Analysis

Figure 7. North America Medical Marijuana Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

Figure 9. Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

Figure 12. Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

Figure 21. Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America Medical Marijuana Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

Figure 26. US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000